Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors

Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors

Abstract Malignant brain tumors consist of malignancies originated primarily within the brain and the metastatic lesions disseminated from other organs. In spite of intensive studies, malignant brain tumors remain to be a medical challenge. Patient-derived organoid (PDO) can recapitulate the biologi...

Full description

Bibliographic Details
Main Authors: Chun-Chung Chen, Hong-Wei Li, Yuan-Liang Wang, Chuan-Chun Lee, Yi-Chun Shen, Ching-Yun Hsieh, Hung-Lin Lin, Xian-Xiu Chen, Der-Yang Cho, Ching-Liang Hsieh, Jeng-Hung Guo, Sung-Tai Wei, John Wang, Shao-Chun Wang
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-20487-y

Internet

https://doi.org/10.1038/s41598-022-20487-y

Similar Items